Merck & Co., Inc.MRKNYSE
LOADING
|||
Operating Income Scaling
Trending higher, above historical average, strong compound growth.
Left:
||||
Profit from core business operations before interest and taxes
Latest
$20.22B
↑ 109% above average
Average (9y)
$9.69B
Historical baseline
Range
High:$20.22B
Low:$2.95B
CAGR
+11.6%
Consistent expansion
| Period | Value | Change |
|---|---|---|
| 2024 | $20.22B | +584.5% |
| 2023 | $2.95B | -83.8% |
| 2022 | $18.28B | +38.5% |
| 2021 | $13.20B | +137.9% |
| 2020 | $5.55B | -30.0% |
| 2019 | $7.93B | -11.3% |
| 2018 | $8.93B | +31.4% |
| 2017 | $6.80B | +23.6% |
| 2016 | $5.50B | -27.1% |
| 2015 | $7.55B | - |